세계의 두개내 스텐트 시장 : 유형별, 용도별, 최종사용자별, 지역별(2025-2033년)

The global intracranial stents market size reached USD 473.4 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,185.6 Million by 2033, exhibiting a growth rate (CAGR) of 10.2% during 2025-2033. The rising prevalence of various cerebrovascular disorders, rapidly growing geriatric population, and shifting preference among patients and healthcare providers towards non-invasive and minimally invasive procedures represent some of the key factors driving the market.

Intracranial stents refer to small, tubular medical devices that are made from biocompatible materials such as nitinol or stainless steel, specifically designed for treating various cerebrovascular conditions in a less invasive way. They are characterized by improved compatibility with multiple imaging techniques, allowing precise navigation through blood vessels and are therefore deployed at the target site, with various sizes and configurations available to accommodate individual anatomical features. They are most commonly installed within narrowed or weakened blood vessels in the brain to provide structural support and restore blood flow. By maintaining vessel patency, they provide enhanced blood flow to the brain which helps in reducing the risk of stroke and other complications associated with restricted or damaged blood vessels. Intracranial stents find extensive applications in surgeries and procedures such as angioplasty or endovascular coiling, to treat various conditions including intracranial aneurysms or stenosis. Some of the advantages provided by intracranial stents include long-term support to blood vessels, shorter recovery times, and reduced hospital stays.

Intracranial Stents Market Trends:

The global market is primarily driven by the rising prevalence of various cerebrovascular disorders such as cerebral aneurysms and strokes. This can be attributed to the rapidly growing geriatric population that is more susceptible to developing these ailments. In line with this, continual technological advancements in intracranial stent production resulting in innovative and advanced products with improved flexibility, navigability, and radial strength are fueling the market. Moreover, an enhanced emphasis on early diagnosis and treatment of neurological conditions is propelling the demand for effective treatment solutions, which in turn is resulting in a higher uptake of intracranial stents. Also, the shifting preference among patients and healthcare providers towards non-invasive and minimally invasive procedures with shorter recovery times is acting as a significant growth-inducing factor for the market. In addition to this, favorable reimbursement policies for intracranial stent procedures by government agencies and private insurance providers in several countries is creating a positive market outlook. The market is further fueled by various strategic collaborations, merger and acquisitions (M&As) and partnerships among key players to expand their market presence. Apart from this, numerous innovations in medical imaging technologies, such as magnetic resonance imaging (MRI), computed tomography (CT), and angiography are impacting the market positively. Some of the other factors contributing to the market include rapid urbanization, rising healthcare expenditure, upgradation of hospital infrastructure, particularly in developing countries and extensive research and development (R&D) activities.

Key Market Segmentation:

Type Insights:

• Self-Expanding Stents
• Balloon Expanding Stents
• Stent-Assisted Coil Embolization

Application Insights:

• Intracranial Stenosis
• Brain Aneurysm

End User Insights:

• Hospitals
• Ambulatory Surgery Centers

Regional Insights:

• North America
• United States
• Canada
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa
• The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for intracranial stents. Some of the factors driving the North America intracranial stents market included growing geriatric population, continual technological advancements, shifting preference towards non-invasive and minimally invasive procedures, high healthcare expenditure, etc.

Competitive Landscape:

• The report has also provided a comprehensive analysis of the competitive landscape in the global intracranial stents market. Detailed profiles of all major companies have been provided. Some of the companies covered include Acandis GmbH, Balt Group, Medtronic Public Limited Company, MicroPort Scientific Corporation, Phenox GmbH, Stryker Corporation, Terumo Corporation, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

• How has the global intracranial stents market performed so far, and how will it perform in the coming years?
• What are the drivers, restraints, and opportunities in the global intracranial stents market?
• What is the impact of each driver, restraint, and opportunity on the global intracranial stents market?
• What are the key regional markets?
• Which countries represent the most attractive intracranial stents market?
• What is the breakup of the market based on the type?
• Which is the most attractive type in the intracranial stents market?
• What is the breakup of the market based on the application?
• Which is the most attractive application in the intracranial stents market?
• What is the breakup of the market based on the end user?
• Which is the most attractive end user in the intracranial stents market?
• What is the competitive structure of the global intracranial stents market?
• Who are the key players/companies in the global intracranial stents market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Intracranial Stents Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Type

• 6.1 Self-Expanding Stents
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Balloon Expanding Stents
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Stent-Assisted Coil Embolization
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by Application

• 7.1 Intracranial Stenosis
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Brain Aneurysm
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by End User

• 8.1 Hospitals
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Ambulatory Surgery Centers
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

• 10.1 Overview
• 10.2 Drivers
• 10.3 Restraints
• 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Acandis GmbH
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
  • 14.3.2 Balt Group
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 Medtronic Public Limited Company
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
  • 14.3.4 MicroPort Scientific Corporation
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 Phenox GmbH
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
  • 14.3.6 Stryker Corporation
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
  • 14.3.7 Terumo Corporation
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.